Reviews CellCept


No reviews yet.

CellCept Drug Description
CellCept®
(mycophenolate mofetil) Tablets and Capsules
CellCept®
(mycophenolate mofetil) for Oral Suspension
CellCept®
(mycophenolate mofetil hydrochloride) for Injection Intravenous

WARNING
Immunosuppression may lead to increased susceptibility to infection and
possible development of lymphoma. Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should
use CellCept. Patients receiving the drug should be managed in facilities equipped
and staffed with adequate laboratory and supportive medical resources. The physician
responsible for maintenance therapy should have complete information requisite
for the follow-up of the patient.
Female users of childbearing potential must use contraception. Use of CellCept
during pregnancy is associated with increased risk of pregnancy loss and congenital
malformations.

DRUG DESCRIPTION



What are the possible side effects of mycophenolate mofetil (CellCept)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using mycophenolate mofetil and call your doctor at once if you have any of these serious side effects:

fever, chills, body aches, flu symptoms;
easy bruising or bleeding, unusual weakness;
coughing up blood or vomit that looks like coffee grounds;
bloody, black, or tarry...
Read All Potential Side Effects for CellCept »




CellCept (mycophenolate mofetil) is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent; inosine monophosphate dehydrogenase (IMPDH) inhibitor.
The chemical name for mycophenolate mofetil (MMF) is 2-morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
It has an empirical formula of C23H31NO7, a
molecular weight of 433.50, and the following structural formula:








Mycophenolate mofetil is a white to off-white crystalline powder. It is slightly soluble in water (43 µg/mL at pH 7.4); the solubility increases in acidic medium (4.27 mg/mL at pH 3.6). It is freely soluble in acetone, soluble in methanol, and sparingly soluble in ethanol. The apparent partition coefficient in 1-octanol/water (pH 7.4) buffer solution is 238. The pKa values for mycophenolate mofetil are 5.6 for the morpholino group and 8.5 for the phenolic group.
Mycophenolate mofetil hydrochloride has a solubility of 65.8 mg/mL in 5% Dextrose Injection USP (D5W). The pH of the reconstituted solution is 2.4 to 4.1.
CellCept is available for oral administration as capsules containing 250 mg of mycophenolate mofetil, tablets containing 500 mg of mycophenolate mofetil, and as a powder for oral suspension, which when constituted contains 200 mg/mL mycophenolate mofetil.
Inactive ingredients in CellCept 250 mg capsules include croscarmellose sodium, magnesium stearate, povidone (K-90) and pregelatinized starch. The capsule shells contain black iron oxide, FD&C blue #2, gelatin, red iron oxide, silicon dioxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
Inactive ingredients in CellCept 500 mg tablets include black iron oxide, croscarmellose sodium, FD&C blue #2 aluminum lake, hydroxypropyl cellulose, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, povidone (K-90), red iron oxide, talc, and titanium dioxide; may also contain ammonium hydroxide, ethyl alcohol, methyl alcohol, n-butyl alcohol, propylene glycol, and shellac.
Inactive ingredients in CellCept Oral Suspension include aspartame, citric acid anhydrous, colloidal silicon dioxide, methylparaben, mixed fruit flavor, sodium citrate dihydrate, sorbitol, soybean lecithin, and xanthan gum.
CellCept Intravenous is the hydrochloride salt of mycophenolate mofetil. The
chemical name for the hydrochloride salt of mycophenolate mofetil is 2-morpholinoethyl
(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
hydrochloride. It has an empirical formula of C23H31NO7
HCl and a molecular weight of 469.96.
CellCept Intravenous is available as a sterile white to off-white lyophilized
powder in vials containing mycophenolate mofetil hydrochloride for administration
by intravenous infusion only. Each vial of CellCept Intravenous contains the
equivalent of 500 mg mycophenolate mofetil as the hydrochloride salt. The inactive
ingredients are polysorbate 80, 25 mg, and citric acid, 5 mg. Sodium hydroxide
may have been used in the manufacture of CellCept Intravenous to adjust the
pH. Reconstitution and dilution with 5% Dextrose Injection USP yields a slightly
yellow solution of mycophenolate mofetil, 6 mg/mL. (For detailed method of preparation,
see DOSAGE AND ADMINISTRATION).Last reviewed on RxList: 10/27/2009




CellCept Drug Description
CellCept®
(mycophenolate mofetil) Tablets and Capsules
CellCept®
(mycophenolate mofetil) for Oral Suspension
CellCept®
(mycophenolate mofetil hydrochloride) for Injection Intravenous

WARNING
Immunosuppression may lead to increased susceptibility to infection and
possible development of lymphoma. Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should
use CellCept. Patients receiving the drug should be managed in facilities equipped
and staffed with adequate laboratory and supportive medical resources. The physician
responsible for maintenance therapy should have complete information requisite
for the follow-up of the patient.
Female users of childbearing potential must use contraception. Use of CellCept
during pregnancy is associated with increased risk of pregnancy loss and congenital
malformations.

DRUG DESCRIPTION



What are the possible side effects of mycophenolate mofetil (CellCept)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using mycophenolate mofetil and call your doctor at once if you have any of these serious side effects:

fever, chills, body aches, flu symptoms;
easy bruising or bleeding, unusual weakness;
coughing up blood or vomit that looks like coffee grounds;
bloody, black, or tarry...
Read All Potential Side Effects for CellCept »




CellCept (mycophenolate mofetil) is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent; inosine monophosphate dehydrogenase (IMPDH) inhibitor.
The chemical name for mycophenolate mofetil (MMF) is 2-morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
It has an empirical formula of C23H31NO7, a
molecular weight of 433.50, and the following structural formula:








Mycophenolate mofetil is a white to off-white crystalline powder. It is slightly soluble in water (43 µg/mL at pH 7.4); the solubility increases in acidic medium (4.27 mg/mL at pH 3.6). It is freely soluble in acetone, soluble in methanol, and sparingly soluble in ethanol. The apparent partition coefficient in 1-octanol/water (pH 7.4) buffer solution is 238. The pKa values for mycophenolate mofetil are 5.6 for the morpholino group and 8.5 for the phenolic group.
Mycophenolate mofetil hydrochloride has a solubility of 65.8 mg/mL in 5% Dextrose Injection USP (D5W). The pH of the reconstituted solution is 2.4 to 4.1.
CellCept is available for oral administration as capsules containing 250 mg of mycophenolate mofetil, tablets containing 500 mg of mycophenolate mofetil, and as a powder for oral suspension, which when constituted contains 200 mg/mL mycophenolate mofetil.
Inactive ingredients in CellCept 250 mg capsules include croscarmellose sodium, magnesium stearate, povidone (K-90) and pregelatinized starch. The capsule shells contain black iron oxide, FD&C blue #2, gelatin, red iron oxide, silicon dioxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
Inactive ingredients in CellCept 500 mg tablets include black iron oxide, croscarmellose sodium, FD&C blue #2 aluminum lake, hydroxypropyl cellulose, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, povidone (K-90), red iron oxide, talc, and titanium dioxide; may also contain ammonium hydroxide, ethyl alcohol, methyl alcohol, n-butyl alcohol, propylene glycol, and shellac.
Inactive ingredients in CellCept Oral Suspension include aspartame, citric acid anhydrous, colloidal silicon dioxide, methylparaben, mixed fruit flavor, sodium citrate dihydrate, sorbitol, soybean lecithin, and xanthan gum.
CellCept Intravenous is the hydrochloride salt of mycophenolate mofetil. The
chemical name for the hydrochloride salt of mycophenolate mofetil is 2-morpholinoethyl
(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
hydrochloride. It has an empirical formula of C23H31NO7
HCl and a molecular weight of 469.96.
CellCept Intravenous is available as a sterile white to off-white lyophilized
powder in vials containing mycophenolate mofetil hydrochloride for administration
by intravenous infusion only. Each vial of CellCept Intravenous contains the
equivalent of 500 mg mycophenolate mofetil as the hydrochloride salt. The inactive
ingredients are polysorbate 80, 25 mg, and citric acid, 5 mg. Sodium hydroxide
may have been used in the manufacture of CellCept Intravenous to adjust the
pH. Reconstitution and dilution with 5% Dextrose Injection USP yields a slightly
yellow solution of mycophenolate mofetil, 6 mg/mL. (For detailed method of preparation,
see DOSAGE AND ADMINISTRATION).Last reviewed on RxList: 10/27/2009




CellCept Drug Description
CellCept®
(mycophenolate mofetil) Tablets and Capsules
CellCept®
(mycophenolate mofetil) for Oral Suspension
CellCept®
(mycophenolate mofetil hydrochloride) for Injection Intravenous

WARNING
Immunosuppression may lead to increased susceptibility to infection and
possible development of lymphoma. Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should
use CellCept. Patients receiving the drug should be managed in facilities equipped
and staffed with adequate laboratory and supportive medical resources. The physician
responsible for maintenance therapy should have complete information requisite
for the follow-up of the patient.
Female users of childbearing potential must use contraception. Use of CellCept
during pregnancy is associated with increased risk of pregnancy loss and congenital
malformations.

DRUG DESCRIPTION



What are the possible side effects of mycophenolate mofetil (CellCept)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using mycophenolate mofetil and call your doctor at once if you have any of these serious side effects:

fever, chills, body aches, flu symptoms;
easy bruising or bleeding, unusual weakness;
coughing up blood or vomit that looks like coffee grounds;
bloody, black, or tarry...
Read All Potential Side Effects for CellCept »




CellCept (mycophenolate mofetil) is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent; inosine monophosphate dehydrogenase (IMPDH) inhibitor.
The chemical name for mycophenolate mofetil (MMF) is 2-morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
It has an empirical formula of C23H31NO7, a
molecular weight of 433.50, and the following structural formula:








Mycophenolate mofetil is a white to off-white crystalline powder. It is slightly soluble in water (43 µg/mL at pH 7.4); the solubility increases in acidic medium (4.27 mg/mL at pH 3.6). It is freely soluble in acetone, soluble in methanol, and sparingly soluble in ethanol. The apparent partition coefficient in 1-octanol/water (pH 7.4) buffer solution is 238. The pKa values for mycophenolate mofetil are 5.6 for the morpholino group and 8.5 for the phenolic group.
Mycophenolate mofetil hydrochloride has a solubility of 65.8 mg/mL in 5% Dextrose Injection USP (D5W). The pH of the reconstituted solution is 2.4 to 4.1.
CellCept is available for oral administration as capsules containing 250 mg of mycophenolate mofetil, tablets containing 500 mg of mycophenolate mofetil, and as a powder for oral suspension, which when constituted contains 200 mg/mL mycophenolate mofetil.
Inactive ingredients in CellCept 250 mg capsules include croscarmellose sodium, magnesium stearate, povidone (K-90) and pregelatinized starch. The capsule shells contain black iron oxide, FD&C blue #2, gelatin, red iron oxide, silicon dioxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
Inactive ingredients in CellCept 500 mg tablets include black iron oxide, croscarmellose sodium, FD&C blue #2 aluminum lake, hydroxypropyl cellulose, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, povidone (K-90), red iron oxide, talc, and titanium dioxide; may also contain ammonium hydroxide, ethyl alcohol, methyl alcohol, n-butyl alcohol, propylene glycol, and shellac.
Inactive ingredients in CellCept Oral Suspension include aspartame, citric acid anhydrous, colloidal silicon dioxide, methylparaben, mixed fruit flavor, sodium citrate dihydrate, sorbitol, soybean lecithin, and xanthan gum.
CellCept Intravenous is the hydrochloride salt of mycophenolate mofetil. The
chemical name for the hydrochloride salt of mycophenolate mofetil is 2-morpholinoethyl
(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
hydrochloride. It has an empirical formula of C23H31NO7
HCl and a molecular weight of 469.96.
CellCept Intravenous is available as a sterile white to off-white lyophilized
powder in vials containing mycophenolate mofetil hydrochloride for administration
by intravenous infusion only. Each vial of CellCept Intravenous contains the
equivalent of 500 mg mycophenolate mofetil as the hydrochloride salt. The inactive
ingredients are polysorbate 80, 25 mg, and citric acid, 5 mg. Sodium hydroxide
may have been used in the manufacture of CellCept Intravenous to adjust the
pH. Reconstitution and dilution with 5% Dextrose Injection USP yields a slightly
yellow solution of mycophenolate mofetil, 6 mg/mL. (For detailed method of preparation,
see DOSAGE AND ADMINISTRATION).Last reviewed on RxList: 10/27/2009




CellCept Drug Description
CellCept®
(mycophenolate mofetil) Tablets and Capsules
CellCept®
(mycophenolate mofetil) for Oral Suspension
CellCept®
(mycophenolate mofetil hydrochloride) for Injection Intravenous

WARNING
Immunosuppression may lead to increased susceptibility to infection and
possible development of lymphoma. Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should
use CellCept. Patients receiving the drug should be managed in facilities equipped
and staffed with adequate laboratory and supportive medical resources. The physician
responsible for maintenance therapy should have complete information requisite
for the follow-up of the patient.
Female users of childbearing potential must use contraception. Use of CellCept
during pregnancy is associated with increased risk of pregnancy loss and congenital
malformations.

DRUG DESCRIPTION



What are the possible side effects of mycophenolate mofetil (CellCept)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using mycophenolate mofetil and call your doctor at once if you have any of these serious side effects:

fever, chills, body aches, flu symptoms;
easy bruising or bleeding, unusual weakness;
coughing up blood or vomit that looks like coffee grounds;
bloody, black, or tarry...
Read All Potential Side Effects for CellCept »




CellCept (mycophenolate mofetil) is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent; inosine monophosphate dehydrogenase (IMPDH) inhibitor.
The chemical name for mycophenolate mofetil (MMF) is 2-morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
It has an empirical formula of C23H31NO7, a
molecular weight of 433.50, and the following structural formula:








Mycophenolate mofetil is a white to off-white crystalline powder. It is slightly soluble in water (43 µg/mL at pH 7.4); the solubility increases in acidic medium (4.27 mg/mL at pH 3.6). It is freely soluble in acetone, soluble in methanol, and sparingly soluble in ethanol. The apparent partition coefficient in 1-octanol/water (pH 7.4) buffer solution is 238. The pKa values for mycophenolate mofetil are 5.6 for the morpholino group and 8.5 for the phenolic group.
Mycophenolate mofetil hydrochloride has a solubility of 65.8 mg/mL in 5% Dextrose Injection USP (D5W). The pH of the reconstituted solution is 2.4 to 4.1.
CellCept is available for oral administration as capsules containing 250 mg of mycophenolate mofetil, tablets containing 500 mg of mycophenolate mofetil, and as a powder for oral suspension, which when constituted contains 200 mg/mL mycophenolate mofetil.
Inactive ingredients in CellCept 250 mg capsules include croscarmellose sodium, magnesium stearate, povidone (K-90) and pregelatinized starch. The capsule shells contain black iron oxide, FD&C blue #2, gelatin, red iron oxide, silicon dioxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
Inactive ingredients in CellCept 500 mg tablets include black iron oxide, croscarmellose sodium, FD&C blue #2 aluminum lake, hydroxypropyl cellulose, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, povidone (K-90), red iron oxide, talc, and titanium dioxide; may also contain ammonium hydroxide, ethyl alcohol, methyl alcohol, n-butyl alcohol, propylene glycol, and shellac.
Inactive ingredients in CellCept Oral Suspension include aspartame, citric acid anhydrous, colloidal silicon dioxide, methylparaben, mixed fruit flavor, sodium citrate dihydrate, sorbitol, soybean lecithin, and xanthan gum.
CellCept Intravenous is the hydrochloride salt of mycophenolate mofetil. The
chemical name for the hydrochloride salt of mycophenolate mofetil is 2-morpholinoethyl
(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
hydrochloride. It has an empirical formula of C23H31NO7
HCl and a molecular weight of 469.96.
CellCept Intravenous is available as a sterile white to off-white lyophilized
powder in vials containing mycophenolate mofetil hydrochloride for administration
by intravenous infusion only. Each vial of CellCept Intravenous contains the
equivalent of 500 mg mycophenolate mofetil as the hydrochloride salt. The inactive
ingredients are polysorbate 80, 25 mg, and citric acid, 5 mg. Sodium hydroxide
may have been used in the manufacture of CellCept Intravenous to adjust the
pH. Reconstitution and dilution with 5% Dextrose Injection USP yields a slightly
yellow solution of mycophenolate mofetil, 6 mg/mL. (For detailed method of preparation,
see DOSAGE AND ADMINISTRATION).Last reviewed on RxList: 10/27/2009




CellCept Drug Description
CellCept®
(mycophenolate mofetil) Tablets and Capsules
CellCept®
(mycophenolate mofetil) for Oral Suspension
CellCept®
(mycophenolate mofetil hydrochloride) for Injection Intravenous

WARNING
Immunosuppression may lead to increased susceptibility to infection and
possible development of lymphoma. Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should
use CellCept. Patients receiving the drug should be managed in facilities equipped
and staffed with adequate laboratory and supportive medical resources. The physician
responsible for maintenance therapy should have complete information requisite
for the follow-up of the patient.
Female users of childbearing potential must use contraception. Use of CellCept
during pregnancy is associated with increased risk of pregnancy loss and congenital
malformations.

DRUG DESCRIPTION



What are the possible side effects of mycophenolate mofetil (CellCept)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using mycophenolate mofetil and call your doctor at once if you have any of these serious side effects:

fever, chills, body aches, flu symptoms;
easy bruising or bleeding, unusual weakness;
coughing up blood or vomit that looks like coffee grounds;
bloody, black, or tarry...
Read All Potential Side Effects for CellCept »




CellCept (mycophenolate mofetil) is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent; inosine monophosphate dehydrogenase (IMPDH) inhibitor.
The chemical name for mycophenolate mofetil (MMF) is 2-morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate.
It has an empirical formula of C23H31NO7, a
molecular weight of 433.50, and the following structural formula:








Mycophenolate mofetil is a white to off-white crystalline powder. It is slightly soluble in water (43 µg/mL at pH 7.4); the solubility increases in acidic medium (4.27 mg/mL at pH 3.6). It is freely soluble in acetone, soluble in methanol, and sparingly soluble in ethanol. The apparent partition coefficient in 1-octanol/water (pH 7.4) buffer solution is 238. The pKa values for mycophenolate mofetil are 5.6 for the morpholino group and 8.5 for the phenolic group.
Mycophenolate mofetil hydrochloride has a solubility of 65.8 mg/mL in 5% Dextrose Injection USP (D5W). The pH of the reconstituted solution is 2.4 to 4.1.
CellCept is available for oral administration as capsules containing 250 mg of mycophenolate mofetil, tablets containing 500 mg of mycophenolate mofetil, and as a powder for oral suspension, which when constituted contains 200 mg/mL mycophenolate mofetil.
Inactive ingredients in CellCept 250 mg capsules include croscarmellose sodium, magnesium stearate, povidone (K-90) and pregelatinized starch. The capsule shells contain black iron oxide, FD&C blue #2, gelatin, red iron oxide, silicon dioxide, sodium lauryl sulfate, titanium dioxide, and yellow iron oxide.
Inactive ingredients in CellCept 500 mg tablets include black iron oxide, croscarmellose sodium, FD&C blue #2 aluminum lake, hydroxypropyl cellulose, hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, povidone (K-90), red iron oxide, talc, and titanium dioxide; may also contain ammonium hydroxide, ethyl alcohol, methyl alcohol, n-butyl alcohol, propylene glycol, and shellac.
Inactive ingredients in CellCept Oral Suspension include aspartame, citric acid anhydrous, colloidal silicon dioxide, methylparaben, mixed fruit flavor, sodium citrate dihydrate, sorbitol, soybean lecithin, and xanthan gum.
CellCept Intravenous is the hydrochloride salt of mycophenolate mofetil. The
chemical name for the hydrochloride salt of mycophenolate mofetil is 2-morpholinoethyl
(E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate
hydrochloride. It has an empirical formula of C23H31NO7
HCl and a molecular weight of 469.96.
CellCept Intravenous is available as a sterile white to off-white lyophilized
powder in vials containing mycophenolate mofetil hydrochloride for administration
by intravenous infusion only. Each vial of CellCept Intravenous contains the
equivalent of 500 mg mycophenolate mofetil as the hydrochloride salt. The inactive
ingredients are polysorbate 80, 25 mg, and citric acid, 5 mg. Sodium hydroxide
may have been used in the manufacture of CellCept Intravenous to adjust the
pH. Reconstitution and dilution with 5% Dextrose Injection USP yields a slightly
yellow solution of mycophenolate mofetil, 6 mg/mL. (For detailed method of preparation,
see DOSAGE AND ADMINISTRATION).Last reviewed on RxList: 10/27/2009





Other reviews about CellCept on wordpress

A Cellcept alternative - Myfortic
  by Michael
Mycophenolate Mofitel (Cellcept) got you down? Suffering from GI distress, cramps, tired of sitting in the bathroom because your Cellcept's killing your stomach? Ask your MD about […]


The FDA has ordered a black box warning on the use of mycophenolate mofetil (CellCept) during pregnancy
  by Law Offices of Sadaka Associates
The FDA has ordered a black box warning on the use of mycophenolate mofetil (CellCept) during pregnancy. In announcing the label change, the agency cited an increased risk of […]


CellCept (mycophenolate mofetil)
  by MarkS
Prescribing information for Mycophenolic Acid (marketed as Myfortic Delayed Released Tablets) revised to include information that use of drug during pregnancy is associated with increased risks of pregnancy […]


Cellcept and Myfortic may induce PML?
  by Michael
FDA issues a Communication About an Ongoing Safety Review of CellCept and Myfortic Communication About an Ongoing Safety Review of CellCept (mycophenolate mofetil) and Myfortic (mycophenolate acid) This information reflects […]


CellCept
  by atypicalms
Currently, I am migrating from Cytoxan-chemo-to CellCept. Yes, cellcept is usually used for transplant patients, but it is an immunosuppressant; therefore, helpful in multiple sclerosis. I am taking […]


Mycophenolate Mofetil [CellCept] Medication Guide
  by thassodotcom
On February 12, 2009, FDA and together with Roche Laboratories notified healthcare professionals of the introduction of a CellCept Medication Guide to provide important safety information in language […]


Health Canada: Important Safety Information on CellCept [Mycophenolate Mofetil] and its Associated Risk for Pure Red Cell Aplasia (PRCA)
  by thassodotcom
June 6, 2009 - From a new posting on Health Canada’s website, we learn that on June 03, 2009, in consultation with Health Canada, Hoffmann-La Roche Limited (Roche), […]


Cellcept Support Resource
  by kellyalpert
The following information was sent via email, I thought I would share this, as Cellcepts patent has expired and a new generic has been released.  My insurance company […]


FDA MedWatch - CellCept (mycophenolate mofetil)
  by irbtipoftheweek
FDA and Roche notified healthcare professionals that cases of Pure Red Cell Aplasia (PRCA) have been reported in patients treated with CellCept. The WARNINGS and ADVERSE REACTIONS sections […]


I'm Bbbbaaaaccckkkk!!!
  by atypicalms
Well, I've taken a bit of a hiatus for personal reasons.  I'm back though and would like to thank everyone who visited this blog while I was away. […]



Other reviews about CellCept on web:

Cellcept (mycophenolate mofetil) is used to prevent rejection of a kidney, liver, or heart transplant. Includes Cellcept side effects, interactions and indications. Cellcept Information from Drugs.com


Accurate, FDA approved CellCept information for healthcare professionals and patients - brought to you by Drugs.com. CellCept Official FDA information, side effects and uses.


Full Prescribing Information (350K/PDF) Medication Guide (118K/PDF) Change in CellCept Label for Pregnancy Outcomes - Dear Health Care Professional Letter - October 2007 (53K/PDF) Genentech: Medicines: CellCept


For easy-to-read pre-transplant booklets on kidney, liver or heart transplant, organ donation and more... Click here CellCept®for Living - Login


Mycophenolic acid is commonly marketed under the trade names CellCept (mycophenolate mofetil; Roche) and Myfortic (mycophenolate sodium; Novartis). Mycophenolic acid - Wikipedia, the free encyclopedia


Find patient medical information for CellCept Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. CellCept Oral : Uses, Side Effects, Interactions, Pictures ...


CellCept is an FDA-approved medication given to patients who have undergone a heart, liver, or kidney transplant. If you or a loved-one has been hurt by CellCept contact a ... CellCept - Defective Drug Lawyer


CellCept is an immunosuppressant used with other medicines to prevent organ rejection following kidney, liver, or heart transplants. Side effects and interactions are available ... Cellcept - drugstore.com. Low prices, side effects, interactions.


What is CellCept (Mycophenolate Mofetil)? Mycophenolate mofetil lowers your body's immune system. The immune system helps your body fight infections. CellCept - Drugs & Treatments - Revolution Health


CellCept Can Cause Miscarriage, Birth Defects, our defective drug side effects lawsuit lawyers will review your case for free. CellCept Miscarriage Birth Defects Lawsuit Lawyers





Featured Reviews

Reviews Nasalide

Nasalide Drug Description DRUG DESCRIPTION Flunisolide, the active component of NASAREL nasal spray, is an anti-inflammatory glucocorticosteroid with the chemical name: 6(alpha)-fluoro-11(beta),16(alpha),17,21 tetrahydroxypregna-1,4-diene-3,20-...
Read More  |  Review This
Reviews Proamatine

Proamatine Drug Description ProAmatine® (midodrine hydrochloride) Tablets WARNING Because ProAmatine® can cause marked elevation of supine blood pressure, it should be used in patients whose lives are considerably impaired...
Read More  |  Review This
Reviews Imodium

Imodium Drug Description IMODIUM® (loperamide hydrochloride), DRUG DESCRIPTION What are the possible side effects of loperamide? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty...
Read More  |  Review This
Reviews Amyl Nitrite Inhalant

Amyl Nitrite Drug Description Amyl Nitrite Inhalant, USP DRUG DESCRIPTION Amyl nitrite is a rapidly acting vasodilator administered by inhalation. 0.3mL is supplied in a covered thin glass capsule which is easily crushed between the...
Read More  |  Review This
Reviews Mycelex

Mycelex Drug Description MYCELEX® (clotrimazole) TROCHE FOR TOPICAL ORAL ADMINISTRATION DRUG DESCRIPTION What are the possible side effects of clotrimazole (Mycelex Troche)? Stop taking clotrimazole and seek emergency medical...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....